National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 6) (No. PB 73 of 2013)

Link to law: https://www.comlaw.gov.au/Details/F2013L01800

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
PB 73 of 2013
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 6)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health , delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated                  14         October 2013
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 6).
         (2)   This Determination may also be cited as PB 73 of 2013.
2              Commencement
                This Determination commences on 1 November 2013.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
[1]     Schedule 1, after item dealing with Tiagabine
 
Omit
 
Tiaprofenic acid